The role of DEXA in obesity and osteoporosis research
Biomedical research is essential for confronting the complex factors that underlie the nation’s major health issues, including skyrocketing obesity and rising osteoporosis in our aging society. InAlyzer® DEXA Systems use dual energy X-ray absorptiometry (DEXA) to measure bone mineral density and body composition in laboratory animals. This simple, quick, and noninvasive technology allows researchers to perform multiple measurements over the lifetime of a lab animal in the investigation of both obesity and osteoporosis. Broadly, DEXA is used to study substances that affect genetics, cell physiology, bone, and soft tissue.
The Centers for Disease Control and Prevention (CDC) demonstrate that 70.7 percent of Americans are either overweight or obese, meaning that an unhealthy weight has become the norm, with normal weight Americans — a BMI of less than 25 — now in the minority. Obesity is one of the leading health issues in the U.S. today and is a key factor in hypertension, type 2 diabetes, coronary heart disease, stroke, gallbladder disease, osteoarthritis, sleep apnea, respiratory problems, dyslipidemia and endometrial, breast, prostate, and colon cancers.
Osteoporosis, the most common bone disease, is a silent condition that affects millions of Americans. Current demographic trends show an increased number of individuals surviving past age 65 and are predictive of rising osteoporotic fractures. The decline in bone mass and raised risk of fracture that accompany aging have Important consequences in increased mortality, which for osteopathic hip fractures extends to 10 years after the fracture.
READ MORE about InAlyzer DEXA applications and uses in bone and body mass research.